Identification of Prognostic Biomarkers in Patients With Malignant Rhabdoid Tumor of the Kidney Based on mTORC1 Signaling Pathway-Related Genes

Background: Malignant rhabdoid tumor of the kidney (MRTK) is an infrequent malignant tumor in childhood, accounting for approximately 2% of all childhood kidney tumors. Although the development of current treatments, the overall survival (OS) rate of MRTK patients is only 25%. The aim of this resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhanghuang, Chenghao, Yao, Zhigang, Tang, Haoyu, Zhang, Kun, Wu, Chengchuang, Li, Li, Xie, Yucheng, Yang, Zhen, Yan, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087638/
https://www.ncbi.nlm.nih.gov/pubmed/35558559
http://dx.doi.org/10.3389/fmolb.2022.843234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087638/
https://www.ncbi.nlm.nih.gov/pubmed/35558559
http://dx.doi.org/10.3389/fmolb.2022.843234

Ejemplares similares